Hope in a Dose: A Cell and Gene Therapy (CGT) Podcast Series
Welcome to Hope in a Dose—the podcast where we explore the science, strategy, and stories behind the therapies redefining what’s possible. Designed for CGT innovators, this series helps you move smarter, faster, and with greater operational confidence.
Across each episode, we unpack the real-world challenges sponsors face today: selecting truly CGT-capable sites, navigating early-phase risk, activating global trials in rare populations, and demonstrating meaningful clinical impact.
Hosted by Lousie Kearney Head of Cell and Gene Therapy, Strategy and Delivery at Fortrea, a seasoned leader with decades of experience guiding emerging biotechs.
Hope in a Dose equips CGT innovators, clinical sites, and Principal Investigators with practical tools to navigate the unique complexities of advanced therapy development.
Episode 1: Breaking Ground: What Makes CGT Trials Different
Discover what sets cell and gene therapy (CGT) clinical trials apart. From “one-and-done” treatments to complex logistics and evolving regulations, our first episode of this podcast series explores the unique challenges and transformative potential of CGT studies. Join us as we dive into science, strategy, and stories behind hope in a dose.
- Host: Louise Kearney, Head of Cell and Gene Therapy, Strategy and Delivery at Fortrea
- Participants: Darby Thomas, Senior Scientific Director for Cell and Gene Therapies, Fortrea